Benefits

Personalised Cancer Treatment

Optosense’s advanced CTC profiling platform significantly improves the precision of cancer treatments by providing real-time, detailed insights into tumor progression. By accurately detecting and enumerating CTCs, our technology enables clinicians to tailor therapies to the specific needs of each patient. This personalized approach not only enhances the effectiveness of treatments but also minimizes unnecessary side effects, leading to better patient outcomes and overall quality of life.

Cost-Effective Healthcare Solutions

Our technology is designed to reduce healthcare costs by improving the efficiency and accuracy of cancer diagnostics. With Optosense’s platform, clinicians can make more informed treatment decisions, reducing the likelihood of ineffective therapies and the need for costly follow-up

More Precise Treatment Decisions

Detailed CTC profiling could give clinicians additional information to support treatment selection and monitor disease progression. By identifying relevant cellular characteristics and biomarkers, OptoSense aims to contribute to more targeted and personalised cancer care.